![Jon T. Holmlund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jon T. Holmlund
No open positions remaining
Profile
Jon T.
Holmlund worked as the Medical Director at Aspire IRB LLC.
He was the Vice President-Development at Ionis Pharmaceuticals, Inc. from 1997 to 2004.
From 2004 to 2007, he served as the Chief Medical Officer & Vice President-Development at Ascenta Therapeutics, Inc. He was also a Principal at the National Cancer Institute.
Dr. Holmlund holds a doctorate degree from the State University of New York at Buffalo.
Former positions of Jon T. Holmlund
| Companies | Position | End |
|---|---|---|
| GALERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/12/2022 |
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer | Chief Tech/Sci/R&D Officer | 31/10/2007 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 29/02/2004 |
Aspire IRB LLC
 Aspire IRB LLC Miscellaneous Commercial ServicesCommercial Services Operates as an independent review board providing human subject protection oversight in clinical trials for life science companies | Chief Tech/Sci/R&D Officer | - |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Training of Jon T. Holmlund
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
36
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Aspire IRB LLC
Aspire IRB LLC Miscellaneous Commercial ServicesCommercial Services Operates as an independent review board providing human subject protection oversight in clinical trials for life science companies | Commercial Services |
- Stock Market
- Insiders
- Jon T. Holmlund
